{"transactions":[{"id":710579,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-13T20:05:53.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."}],"balance_after":0,"derivative":{"exercise_price":0.87,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001628280-26-048012","document":"wk-form4_1783973150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026048012/wk-form4_1783973150.xml","form_type":"4"}},{"id":710578,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-13T20:05:53.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."}],"balance_after":0,"derivative":{"exercise_price":2.25,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001628280-26-048012","document":"wk-form4_1783973150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026048012/wk-form4_1783973150.xml","form_type":"4"}},{"id":710577,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-13T20:05:53.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."}],"balance_after":0,"derivative":{"exercise_price":1.37,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001628280-26-048012","document":"wk-form4_1783973150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026048012/wk-form4_1783973150.xml","form_type":"4"}},{"id":710576,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:05:53.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":177523,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the Effective Time, each share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") was converted into the right to receive (a) an amount in cash equal to $3.16 per share, without interest (the \"per share cash consideration\"), and (b) one contractual contingent value right per share (each, a \"CVR\" and, together with the per share cash consideration, the \"merger consideration\"), representing the right to participate in contingent payments in cash, without interest, upon the achievement of certain milestones, subject to any applicable withholding taxes. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 79,873 restricted stock units (each, a \"RSU\"). At the Effective Time, each RSU with respect to Common Stock outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested), and was canceled and converted into the right to receive, with respect to each share of Common Stock subject to such RSU immediately prior to the effective time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the per share cash consideration, plus (b) one CVR, subject to certain exceptions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") was converted into the right to receive (a) an amount in cash equal to $3.16 per share, without interest (the \"per share cash consideration\"), and (b) one contractual contingent value right per share (each, a \"CVR\" and, together with the per share cash consideration, the \"merger consideration\"), representing the right to participate in contingent payments in cash, without interest, upon the achievement of certain milestones, subject to any applicable withholding taxes. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Includes 79,873 restricted stock units (each, a \"RSU\"). At the Effective Time, each RSU with respect to Common Stock outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested), and was canceled and converted into the right to receive, with respect to each share of Common Stock subject to such RSU immediately prior to the effective time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the per share cash consideration, plus (b) one CVR, subject to certain exceptions."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-26-048012","document":"wk-form4_1783973150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026048012/wk-form4_1783973150.xml","form_type":"4"}},{"id":756928,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-01T20:22:35.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":79873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) May 28, 2027 and (ii) the Issuer's next annual meeting of stockholders following May 28, 2026."}],"balance_after":177523,"source":{"system":"sec-edgar","filing":"0001628280-26-039520","document":"wk-form4_1780345352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026039520/wk-form4_1780345352.xml","form_type":"4"}},{"id":1127517,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T20:10:49.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest in full on the earlier of (i) May 29, 2026 and (ii) the Issuer's next annual meeting of stockholders following May 29, 2025."}],"balance_after":44000,"derivative":{"exercise_price":0.87,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001628280-25-028830","document":"wk-form4_1748895041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025028830/wk-form4_1748895041.xml","form_type":"4"}},{"id":1127516,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T20:10:49.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) May 29, 2026 and (ii) the Issuer's next annual meeting of stockholders following May 29, 2025."}],"balance_after":97650,"source":{"system":"sec-edgar","filing":"0001628280-25-028830","document":"wk-form4_1748895041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025028830/wk-form4_1748895041.xml","form_type":"4"}},{"id":1326478,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-18T17:57:08.000Z","date":"2024-12-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32734,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 18, 2024, Creek Parent, Inc., a Delaware corporation (\"Parent\"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (\"Merger Sub\"), dated as of February 5, 2024 (the \"Merger Agreement\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-137708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095017024137708/ownership.xml","form_type":"4"}},{"id":1378112,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-01T21:04:22.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":4663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of (i) a \"change in control\" (as defined in the Catalent, Inc. 2018 Omnibus Incentive Plan) and (ii) one year from the date of award, subject to continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":32734,"source":{"system":"sec-edgar","filing":"0001596783-24-000101","document":"wk-form4_1730495055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678324000101/wk-form4_1730495055.xml","form_type":"4"}},{"id":1501846,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-24T20:18:52.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest in full on the earlier of (i) May 23, 2025 and (ii) the Issuer's next annual meeting of stockholders following May 23, 2024."}],"balance_after":32500,"derivative":{"exercise_price":2.25,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001628280-24-025223","document":"wk-form4_1716581904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024025223/wk-form4_1716581904.xml","form_type":"4"}},{"id":1501845,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-24T20:18:52.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) May 23, 2025 and (ii) the Issuer's next annual meeting of stockholders following May 23, 2024."}],"balance_after":64650,"source":{"system":"sec-edgar","filing":"0001628280-24-025223","document":"wk-form4_1716581904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024025223/wk-form4_1716581904.xml","form_type":"4"}},{"id":1753092,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-31T21:04:59.000Z","date":"2023-10-27","kind":"grant","planned":false,"acquired":true,"shares":6993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award, subject to continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":28071,"source":{"system":"sec-edgar","filing":"0001596783-23-000159","document":"wk-form4_1698786289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678323000159/wk-form4_1698786289.xml","form_type":"4"}},{"id":1832811,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T20:41:05.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The equity acquired by the reporting person is the regular, annual grant of restricted stock units (pro-rated to reflect a partial year of service in a new role) provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":21078,"source":{"system":"sec-edgar","filing":"0001596783-23-000044","document":"wf-form4_168876245096139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678323000044/wf-form4_168876245096139.xml","form_type":"4"}},{"id":1851954,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:08:03.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest in full on the earlier of (i) June 15, 2024 and (ii) the Issuer's next annual meeting of stockholders following June 15, 2023."}],"balance_after":21000,"derivative":{"exercise_price":1.37,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001628280-23-022457","document":"wf-form4_168694606782252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023022457/wf-form4_168694606782252.xml","form_type":"4"}},{"id":1851953,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:08:03.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":5150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) June 15, 2024 and (ii) the Issuer's next annual meeting of stockholders following June 15, 2023."}],"balance_after":41650,"source":{"system":"sec-edgar","filing":"0001628280-23-022457","document":"wf-form4_168694606782252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023022457/wf-form4_168694606782252.xml","form_type":"4"}},{"id":1896652,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-11T20:11:27.000Z","date":"2023-05-11","kind":"purchase","planned":false,"acquired":true,"shares":23091,"price":1.5714,"value":36285.1974,"ownership":{"direct":true},"balance_after":36500,"source":{"system":"sec-edgar","filing":"0001628280-23-017563","document":"wf-form4_168383586976164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023017563/wf-form4_168383586976164.xml","form_type":"4"}},{"id":1896651,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-11T20:11:27.000Z","date":"2023-05-10","kind":"purchase","planned":false,"acquired":true,"shares":8409,"price":1.4919,"value":12545.3871,"ownership":{"direct":true},"balance_after":13409,"source":{"system":"sec-edgar","filing":"0001628280-23-017563","document":"wf-form4_168383586976164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023017563/wf-form4_168383586976164.xml","form_type":"4"}},{"id":2129441,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-31T20:40:15.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":4149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2023 annual meeting of shareholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":20523,"source":{"system":"sec-edgar","filing":"0001596783-22-000163","document":"wf-form4_166724880116085.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678322000163/wf-form4_166724880116085.xml","form_type":"4"}},{"id":2244418,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:11:40.000Z","date":"2022-06-02","kind":"purchase","acquired":true,"shares":5000,"price":5.6359,"value":28179.5,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001628280-22-016165","document":"wf-form4_165428708283768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022016165/wf-form4_165428708283768.xml","form_type":"4"}},{"id":2249416,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-01T20:24:33.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest over a three (3) year period in equal annual installments, the first of which will be June 1, 2023."}],"balance_after":40000,"derivative":{"exercise_price":5.42,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001628280-22-015913","document":"wf-form4_165411505026295.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022015913/wf-form4_165411505026295.xml","form_type":"4"}},{"id":2490401,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T18:41:49.000Z","date":"2021-11-29","kind":"other","acquired":true,"shares":3136,"price":134.12,"value":420600.32,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction involves the transfer of shares of the Issuer's common stock to a trust in exchange for assets of equal value."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The average of the low and high price for the Issuer's common stock on the date of transfer."}],"balance_after":11663,"source":{"system":"sec-edgar","filing":"0001596783-21-000194","document":"wf-form4_163838409585752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678321000194/wf-form4_163838409585752.xml","form_type":"4"}},{"id":2490400,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T18:41:49.000Z","date":"2021-11-29","kind":"other","acquired":false,"shares":3136,"price":134.12,"value":420600.32,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction involves the transfer of shares of the Issuer's common stock to a trust in exchange for assets of equal value."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The average of the low and high price for the Issuer's common stock on the date of transfer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001596783-21-000194","document":"wf-form4_163838409585752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678321000194/wf-form4_163838409585752.xml","form_type":"4"}},{"id":2490399,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T18:41:49.000Z","date":"2021-11-29","kind":"gift","acquired":true,"shares":3136,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":3136,"source":{"system":"sec-edgar","filing":"0001596783-21-000194","document":"wf-form4_163838409585752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678321000194/wf-form4_163838409585752.xml","form_type":"4"}},{"id":2490398,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T18:41:49.000Z","date":"2021-11-29","kind":"gift","acquired":false,"shares":3136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units."}],"balance_after":16374,"source":{"system":"sec-edgar","filing":"0001596783-21-000194","document":"wf-form4_163838409585752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678321000194/wf-form4_163838409585752.xml","form_type":"4"}},{"id":2530516,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-01T11:59:40.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":1402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2022 annual meeting of shareholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":19510,"source":{"system":"sec-edgar","filing":"0001596783-21-000169","document":"wf-form4_163576796826101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678321000169/wf-form4_163576796826101.xml","form_type":"4"}},{"id":2606307,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-08-13T01:27:37.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":96864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each RSU represented a contingent right to receive one share of issuer common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested on June 18, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested on June 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each RSU represented a contingent right to receive one share of issuer common stock upon settlement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96864},"source":{"system":"sec-edgar","filing":"0001387131-21-008434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121008434/ownership.xml","form_type":"4"}},{"id":2606306,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T01:27:37.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":96864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021."}],"balance_after":106864,"source":{"system":"sec-edgar","filing":"0001387131-21-008434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121008434/ownership.xml","form_type":"4"}},{"id":2646991,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-07-02T22:11:51.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":99174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022."}],"balance_after":99174,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":99174},"source":{"system":"sec-edgar","filing":"0001387131-21-007137","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121007137/ownership.xml","form_type":"4"}},{"id":2785891,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-16T20:17:35.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":31398,"price":0.4007,"value":12581.1786,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents a weighted average. The shares were sold in multiple transactions at prices ranging from $0.40 to $0.41, inclusive. Mr. Carroll will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950138-21-000222","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013821000222/edgar.xml","form_type":"4"}},{"id":2785890,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-16T20:17:35.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":10667,"price":0.4007,"value":4274.2669,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents a weighted average. The shares were sold in multiple transactions at prices ranging from $0.40 to $0.41, inclusive. Mr. Carroll will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950138-21-000222","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013821000222/edgar.xml","form_type":"4"}},{"id":2996382,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-02T12:20:11.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":2125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2021 annual meeting of shareholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":18108,"source":{"system":"sec-edgar","filing":"0001596783-20-000210","document":"wf-form4_160431959725529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678320000210/wf-form4_160431959725529.xml","form_type":"4"}},{"id":3044493,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-28T22:45:58.000Z","date":"2020-08-27","kind":"grant","acquired":true,"shares":661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity acquired by the reporting person is part of the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. The grant is in respect of the period between July 1, 2020 and the date of the reporting person's annual meeting of shareholders in respect of fiscal 2020. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":15983,"source":{"system":"sec-edgar","filing":"0001596783-20-000140","document":"wf-form4_159865474314284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678320000140/wf-form4_159865474314284.xml","form_type":"4"}},{"id":3104959,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-19T21:07:39.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":96864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on June 18, 2021."}],"balance_after":96864,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96864},"source":{"system":"sec-edgar","filing":"0001387131-20-005815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120005815/ownership.xml","form_type":"4"}},{"id":3147015,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-15T20:13:16.000Z","date":"2020-05-13","kind":"tax_withholding","acquired":false,"shares":8729,"price":2.96,"value":25837.84,"ownership":{"direct":true},"balance_after":10667,"source":{"system":"sec-edgar","filing":"0000950138-20-000255","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013820000255/edgar.xml","form_type":"4"}},{"id":3150615,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-13T21:08:01.000Z","date":"2020-05-12","kind":"other","acquired":true,"shares":3600,"price":72.29,"value":260244.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction involves the transfer of shares of the Issuer's common stock to a trust in exchange for assets of equal value."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The average of the low and high price for the Issuer's common stock on the date of transfer."}],"balance_after":8527,"source":{"system":"sec-edgar","filing":"0001596783-20-000058","document":"wf-form4_158940406188101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678320000058/wf-form4_158940406188101.xml","form_type":"4"}},{"id":3150614,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-13T21:08:01.000Z","date":"2020-05-12","kind":"other","acquired":false,"shares":3600,"price":72.29,"value":260244.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction involves the transfer of shares of the Issuer's common stock to a trust in exchange for assets of equal value."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The average of the low and high price for the Issuer's common stock on the date of transfer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001596783-20-000058","document":"wf-form4_158940406188101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678320000058/wf-form4_158940406188101.xml","form_type":"4"}},{"id":3150613,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-13T21:08:01.000Z","date":"2020-05-12","kind":"gift","acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":3600,"source":{"system":"sec-edgar","filing":"0001596783-20-000058","document":"wf-form4_158940406188101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678320000058/wf-form4_158940406188101.xml","form_type":"4"}},{"id":3150612,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-13T21:08:01.000Z","date":"2020-05-12","kind":"gift","acquired":false,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units."}],"balance_after":15322,"source":{"system":"sec-edgar","filing":"0001596783-20-000058","document":"wf-form4_158940406188101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678320000058/wf-form4_158940406188101.xml","form_type":"4"}},{"id":3429136,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-26T19:45:35.000Z","date":"2019-08-22","kind":"grant","acquired":true,"shares":3167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":18922,"source":{"system":"sec-edgar","filing":"0001596783-19-000151","document":"wf-form4_156684871922500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678319000151/wf-form4_156684871922500.xml","form_type":"4"}},{"id":3459741,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-17T22:53:27.000Z","date":"2019-07-15","kind":"other","acquired":true,"shares":4927,"price":53.24,"value":262313.48,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction involves the transfer of shares of the Issuer's common stock to a trust in exchange for assets of equal value."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The average of the low and high price for the Issuer's common stock on the date of transfer."}],"balance_after":4927,"source":{"system":"sec-edgar","filing":"0001596783-19-000061","document":"wf-form4_156340399171917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678319000061/wf-form4_156340399171917.xml","form_type":"4"}},{"id":3459740,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-17T22:53:27.000Z","date":"2019-07-15","kind":"other","acquired":false,"shares":4927,"price":53.24,"value":262313.48,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction involves the transfer of shares of the Issuer's common stock to a trust in exchange for assets of equal value."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The average of the low and high price for the Issuer's common stock on the date of transfer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001596783-19-000061","document":"wf-form4_156340399171917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678319000061/wf-form4_156340399171917.xml","form_type":"4"}},{"id":3459739,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-17T22:53:27.000Z","date":"2019-07-15","kind":"gift","acquired":true,"shares":4927,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":4927,"source":{"system":"sec-edgar","filing":"0001596783-19-000061","document":"wf-form4_156340399171917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678319000061/wf-form4_156340399171917.xml","form_type":"4"}},{"id":3459738,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-17T22:53:27.000Z","date":"2019-07-15","kind":"gift","acquired":false,"shares":4927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units."}],"balance_after":15755,"source":{"system":"sec-edgar","filing":"0001596783-19-000061","document":"wf-form4_156340399171917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678319000061/wf-form4_156340399171917.xml","form_type":"4"}},{"id":3480825,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-06-24T23:01:19.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":2.64,"exercise_date":"2020-06-20","expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001387131-19-004584","document":"carroll-form4_062019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119004584/carroll-form4_062019.xml","form_type":"4"}},{"id":3504437,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-03T20:14:14.000Z","date":"2019-05-30","kind":"other","acquired":true,"shares":10551,"price":9.19,"value":96963.69,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction involves the transfer of ordinary shares to trust in exchange for assets of equal value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Updated to reflect an additional 360 ordinary shares held by trust that were inadvertently omitted from previous filing due to a typographical error."}],"balance_after":31398,"source":{"system":"sec-edgar","filing":"0000950138-19-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000331/edgar.xml","form_type":"4"}},{"id":3504436,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-03T20:14:14.000Z","date":"2019-05-30","kind":"other","acquired":false,"shares":10551,"price":9.19,"value":96963.69,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction involves the transfer of ordinary shares to trust in exchange for assets of equal value."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950138-19-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000331/edgar.xml","form_type":"4"}},{"id":3504435,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-03T20:14:14.000Z","date":"2019-05-30","kind":"gift","acquired":true,"shares":10551,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":10551,"source":{"system":"sec-edgar","filing":"0000950138-19-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000331/edgar.xml","form_type":"4"}},{"id":3504434,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-03T20:14:14.000Z","date":"2019-05-30","kind":"gift","acquired":false,"shares":10551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Updated to reflect an additional 360 ordinary shares held by trust that were inadvertently omitted from previous filing due to a typographical error."}],"balance_after":19396,"source":{"system":"sec-edgar","filing":"0000950138-19-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000331/edgar.xml","form_type":"4"}},{"id":3520459,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-17T10:49:15.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":19396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units that vest in their entirety as of the date of the Company's 2020 Annual General Meeting. The restricted stock units settle in ordinary shares upon vesting."}],"balance_after":30307,"source":{"system":"sec-edgar","filing":"0000950138-19-000306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000306/edgar.xml","form_type":"4"}},{"id":3520458,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-17T10:49:15.000Z","date":"2019-05-15","kind":"tax_withholding","acquired":false,"shares":8527,"price":15.21,"value":129695.67,"ownership":{"direct":true},"balance_after":10911,"source":{"system":"sec-edgar","filing":"0000950138-19-000306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000306/edgar.xml","form_type":"4"}},{"id":3673927,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-02-05T13:05:22.000Z","date":"2018-06-04","kind":"gift","acquired":true,"shares":20487,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":20487,"source":{"system":"sec-edgar","filing":"0000950138-19-000062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000062/edgar.xml","form_type":"5"}},{"id":3673926,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-02-05T13:05:22.000Z","date":"2018-06-04","kind":"gift","acquired":false,"shares":20487,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950138-19-000062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000062/edgar.xml","form_type":"5"}},{"id":3673925,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-02-05T13:05:22.000Z","date":"2018-05-31","kind":"gift","acquired":true,"shares":20487,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":20487,"source":{"system":"sec-edgar","filing":"0000950138-19-000062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000062/edgar.xml","form_type":"5"}},{"id":3673924,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-02-05T13:05:22.000Z","date":"2018-05-31","kind":"gift","acquired":false,"shares":20487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 131 shares distributed in satisfaction of an annuity by the grantor retained annuity trust to the reporting person, which was exempt from reporting pursuant to Rule 16a-13."}],"balance_after":19438,"source":{"system":"sec-edgar","filing":"0000950138-19-000062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013819000062/edgar.xml","form_type":"5"}},{"id":3833703,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-24T18:46:59.000Z","date":"2018-08-23","kind":"grant","acquired":true,"shares":4183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":20682,"source":{"system":"sec-edgar","filing":"0001596783-18-000065","document":"wf-form4_153513640309017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678318000065/wf-form4_153513640309017.xml","form_type":"4"}},{"id":3873828,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-05T21:00:39.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":6.35,"exercise_date":"2019-07-02","expiration_date":"2028-07-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001387131-18-003026","document":"carroll-form4_070218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118003026/carroll-form4_070218.xml","form_type":"4"}},{"id":3925602,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-18T20:28:31.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":18947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units that vest in their entirety as of the date of the Company's 2019 Annual General Meeting. The restricted stock units settle in ordinary shares upon vesting."}],"balance_after":39794,"source":{"system":"sec-edgar","filing":"0000950138-18-000419","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013818000419/edgar.xml","form_type":"4"}},{"id":4014527,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-03-05T21:50:07.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":2576,"price":15.68,"value":40391.68,"ownership":{"direct":true},"balance_after":20847,"source":{"system":"sec-edgar","filing":"0000950138-18-000226","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013818000226/edgar.xml","form_type":"4"}},{"id":4165292,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-11-13T21:17:27.000Z","date":"2017-11-09","kind":"purchase","acquired":true,"shares":5000,"price":20.4187,"value":102093.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents a weighted average. The shares were purchased in multiple transactions at prices ranging from $20.39 to $20.46, inclusive. Mr. Carroll will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range."}],"balance_after":23423,"source":{"system":"sec-edgar","filing":"0000950138-17-000754","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013817000754/edgar.xml","form_type":"4"}},{"id":4194140,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-10-03T21:04:33.000Z","date":"2017-10-01","kind":"tax_withholding","acquired":false,"shares":476,"price":37.37,"value":17788.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,458 shares which were contributed by the reporting person to a grantor retained annuity trust in August 2016 and 9,327 shares distributed in satisfaction of an annuity by the grantor retained annuity trust to the reporting person in September 2017.  These transactions were exempt from reporting pursuant to Rule 16a-13."}],"balance_after":18423,"source":{"system":"sec-edgar","filing":"0000950138-17-000703","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013817000703/edgar.xml","form_type":"4"}},{"id":4223416,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-28T15:30:30.000Z","date":"2017-08-24","kind":"grant","acquired":true,"shares":3976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package adopted in 2014. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one (1) year from the date of award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":16499,"source":{"system":"sec-edgar","filing":"0001596783-17-000125","document":"wf-form4_150393421613453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000159678317000125/wf-form4_150393421613453.xml","form_type":"4"}},{"id":4274185,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-06-23T20:31:09.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":5.8,"exercise_date":"2018-06-21","expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001387131-17-003412","document":"carroll-form4_062117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713117003412/carroll-form4_062117.xml","form_type":"4"}},{"id":4275185,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-21T20:05:43.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan.  The option shall vest in equal quarterly installments at the end of each quarter following June 20, 2017, subject to continued service through such dates."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-17-016835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924317016835/doc4.xml","form_type":"4"}},{"id":4403360,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-03-04T00:05:05.000Z","date":"2017-03-01","kind":"tax_withholding","acquired":false,"shares":2286,"price":51.55,"value":117843.3,"ownership":{"direct":true},"balance_after":19030,"source":{"system":"sec-edgar","filing":"0000950138-17-000270","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013817000270/edgar.xml","form_type":"4"}},{"id":4403359,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-03-04T00:05:05.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":5723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units that vest in their entirety as of March 1, 2018.  The restricted stock units settle in ordinary shares upon vesting."}],"balance_after":21316,"source":{"system":"sec-edgar","filing":"0000950138-17-000270","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013817000270/edgar.xml","form_type":"4"}},{"id":4513935,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-23T00:11:40.000Z","date":"2016-12-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":5.68,"exercise_date":"2017-12-21","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001387131-16-008709","document":"carroll-form4_12212016.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713116008709/carroll-form4_12212016.xml","form_type":"4"}},{"id":4586459,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":30804,"kind":"person","name":"CARROLL J MARTIN","position":1,"cik":"0001279901","reported_name":"CARROLL J MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2016-10-04T12:55:00.000Z","date":"2016-10-01","kind":"grant","acquired":true,"shares":1057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units that vest in their entirety as of October 1, 2017. The restricted stock units settle in ordinary shares upon vesting."}],"balance_after":15593,"source":{"system":"sec-edgar","filing":"0000950138-16-001369","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279901/000095013816001369/edgar.xml","form_type":"4"}}]}